ArticleCurrent opinion in urology2023

Optimal combination therapy for metastatic hormone-sensitive prostate cancer: new evidence, challenges and unanswered questions.

Fabio Zattoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.